LUPUS and the Genome
Nipurna Jina,
Department of Clinical Biochemistry,
University of Leicester
LUPUS is a complex disease now where have we heard that before?
The statement above tends to be used in the opening paragraph by authors who go on to describe exactly how complex lupus is. Whether you examine SLE and the immune system or the genetic influence in SLE, it is complex! Having read around the subject I will attempt to give you an insight into how scientists are unravelling the disease from where it stems - the genes.
Susceptibility to Lupus
Lupus occurs in individuals who are genetically susceptible or prone to developing the disease depending on their genetic makeup. We inherit our genes from both parents and the combination of genes differs in everyone except identical twins.
Since the 1950s, doctors have been aware that SLE and other autoimmune diseases, such as rheumatoid arthritis, run in families and that the disease may be influenced by genes as well as the environment. Findings from studies of twins with lupus support this view; there is a greater chance of both identical twins developing lupus than non-identical twins. The probability that both twins will express lupus (termed the concordance rate) for identical and non-identical twins is 24% and 2% respectively. This shows that an individuals genes influence lupus, however, concordance rates for identical twins is not 100% suggesting that environmental factors are involved e.g. exposure to UV light.
The familial tendency is also supported in studies of siblings who develop SLE. Siblings predisposed to lupus tend to develop lupus at about the same age and within a few years of each other. Another feature of familial lupus is that family members share similar pathologies or symptoms. In fact research has shown that some unaffected first-degree relatives (immediate family members e.g. sister) may also exhibit one or more of the clinical symptoms e.g. high antibody titre.
Genetic associations in Lupus
Studies were conducted to investigate which genes are commonly found in SLE patients that are different to genes found in healthy people. As SLE is an autoimmune disease, investigators began by looking at genes involved in directing the immune response. These genes include the Human Leucocyte Antigen (HLA):
|
Research has shown that a combination of genes with low penetrance i.e. little effect alone, act together to trigger lupus and contribute to disease progression. These first genes recognised to be associated with SLE have since been found to influence clinical symptoms rather than contribute to the predisposition to lupus.
Search for susceptibility genes
The completion of the human genome project (analysis of all 23 chromosomes) and development of newer genetic techniques paved the way for research groups to scan the entire genome for genes that are linked to lupus. Five studies have so far been completed involving families with one or more affected individuals, including families from various ethnic backgrounds.
Collectively these studies have pointed to regions on chromosomes 1, 2, 4, 6 and 16 which may contain genes that contribute to a susceptibility to lupus. This information considered with other evidence highlights certain hotspots of interest, for example the potential susceptibility regions identified on chromosome 1 have been linked to similar regions found on mouse models of lupus which cause lupus in mice. Also those regions identified on chromosome 6 lie close to or encompass some HLA genes. As these regions help control the immune system this may be a feature in all autoimmune diseases.
Researchers discovered that when these findings were further divided, certain regions were more common to specific racial groups. This may help explain why people from different ethnic backgrounds tend to be susceptible to a separate set of pathologies.
It must be stressed that these regions identified so far give an indication into the area of the genome on which scientists can now focus their research. With the information being gathered from all corners of the globe, scientists are getting closer to understanding the complex disease that is SLE. This will inevitably facilitate improved diagnostic treatments and maybe even tailor them to treat various groups depending on varying disease expression.
Summary
|
Facebook
Twitter
Digg
reddit
Delicious
StumbleUpon 


